↓ Skip to main content

Linoleate-pazopanib conjugation as active pharmacological ingredient to abolish hepatocellular carcinoma growth

Overview of attention for article published in Frontiers in Pharmacology, January 2024
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Linoleate-pazopanib conjugation as active pharmacological ingredient to abolish hepatocellular carcinoma growth
Published in
Frontiers in Pharmacology, January 2024
DOI 10.3389/fphar.2023.1281067
Pubmed ID
Authors

Ke Wang, Pei-Yin Liao, Wei-Chun Chang, Cian-Ru Yang, Yu-Ting Su, Ping-Ching Wu, Yang-Chang Wu, Yao-Ching Hung, Najim Akhtar, Hsueh-Chou Lai, Wen-Lung Ma

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 50%
Student > Ph. D. Student 1 25%
Researcher 1 25%
Readers by discipline Count As %
Unspecified 2 50%
Nursing and Health Professions 1 25%
Business, Management and Accounting 1 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2024.
All research outputs
#16,636,248
of 25,263,619 outputs
Outputs from Frontiers in Pharmacology
#6,319
of 19,478 outputs
Outputs of similar age
#92,196
of 194,903 outputs
Outputs of similar age from Frontiers in Pharmacology
#52
of 421 outputs
Altmetric has tracked 25,263,619 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,478 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,903 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 421 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.